Brazil increases import tariffs on some US medicines
This article was originally published in Scrip
Executive Summary
Brazil's chamber for foreign trade, CAMEX, has published a list of 100 products coming from the US that will be subject to higher import duties following a WTO dispute over cotton subsidies. The list affects some medicines, including those containing paracetamol, but not antiretrovirals, as originally feared.
You may also be interested in...
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.